Inside information potential issuance of shares by CR pharmaceutical commercial
Filed with HKEX · Stock code 3320 · · 2 pages · English
Summary by 6ix AI
China Resources Pharmaceutical Group Ltd. has announced a potential issuance of shares by its subsidiary, CR Pharmaceutical Commercial, through a public bidding process. The pre-bidding process for this potential issuance has commenced via the China Beijing Equity Exchange. No binding agreement has been made regarding the issuance, and there is no guarantee that the transaction will proceed. Shareholders and potential investors are advised to exercise caution in trading the company's securities.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/inside-information-potential-issuance-of-shares-by-cr-pharmaceutical-commercial
China Resources Pharmaceutical Group Ltd. on 6ix
Earlier from China Resources Pharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Interim Report 2026
- Dividend currency election form for the interim dividend for the six months ended 30 June 2026
- AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry
- China Resources Pharmaceutical Logs FY Revenue RMB2.06 Bln For CR Boya Bio-Pharmaceutical
Later from China Resources Pharmaceutical
- Inside information completion of the public issuance of the second tranche of 2026 corporate bonds in the PRC
- Inside information completion of the issue of the third tranche of the medium term notes 2026 in the PRC
- Announcement unaudited financial results of tasly pharmaceutical for the nine months ended 30 September 2026
- Announcement unaudited financial results of dong-e-e-jiao for the nine months ended 30 September 2026
- Announcement unaudited financial results of CR jiangzhong for the nine months ended 30 September 2026
Follow China Resources Pharmaceutical into a list and get an email when it puts out news.
Follow China Resources Pharmaceutical